Top

BY Devon Carter

Immunotherapy harnesses the natural power of the immune system and enhances its response to cancer. Immune checkpoint inhibitors are the most commonly used type of immunotherapy. There are several types, and they all work by interfering with mechanisms on a cancer cell or on a type of immune cell called T cells.

Recently, a new type of immune checkpoint inhibitor called a LAG-3 inhibitor was approved by the Food and Drug Administration...

Illustration of a tumor cell and a T cell and depictions of relatimab and nivolumab breaking the bond.

BY Adrienne DeNooyer

I have always enjoyed an active lifestyle, playing pickleball and taking long walks with my husband, Bill. But in April 2019, I started experiencing...

BY Cynthia DeMarco

When Arav Patil was diagnosed with acute myeloid leukemia (AML) in the spring of 2019, his parents, Komal and Rahul, were dumbfounded....

BY Sandy Goss

I always thought my husband would be the last one to receive a cancer diagnosis.  

Bill had always been very athletic and proactive about his health. Then, in 2008, at age 57, he found a lump under his left arm while taking a shower. As a nurse, I knew this hard, immovable lump was more than just a cyst. A biopsy revealed Bill had metastatic melanoma, with the original site unknown.

We immediately chose MD Anderson...

Bill and Sandy Goss

BY Devon Carter

Cancer research is advancing rapidly, and patients are benefitting from new therapies faster than ever. One example is a type of targeted...

BY Molly Adams

Throughout cancer treatment, patients may go through many blood draws, infusions and injections. All these needle sticks can be uncomfortable...

BY Sairah Ahmed, M.D. and Elizabeth Shpall, M.D.

Since MD Anderson’s first CAR T cell therapy clinical trial launched in 2015, we’ve cared for hundreds of patients undergoing CAR T cell therapy...

BY Meagan Raeke

Neoadjuvant immunotherapy is an immunotherapy that’s started before surgery. It is almost always followed with additional doses of adjuvant...

BY Meagan Raeke

A cancer diagnosis is never good news, but Paul McKinney knows that his stage III melanoma diagnosis at least came at a “good” time in terms...

BY Cynthia DeMarco

Until she came to MD Anderson, 82-year-old Myrna Youmans had never heard the words “smoldering myeloma.” So, she didn’t know that they described...